What's the next stop for IndusInd Bank? CLSA sees 30% upside from current levels. The big contrarian call from CLSA at this hour, it has maintained the Outperform rating on IndusInd Bank now with ...

IndusInd Bank Crisis: CLSA marginally increased credit cost estimates for FY26 due to the microfinance collection issue in Karnataka.(Photo: Bloomberg) Global brokerage CLSA has cut IndusInd Bank ...

JLR volumes at risk from Trump’s proposed 25% tariffs The primary reason behind CLSA’s downgrade is the expected impact of potential US tariffs on auto imports, which could result in a 14 per cent YoY ...

Max Life insurance CLSA's top pick: The private insurance companies’ total APE was up 9% YoY in Feb 2025. (Image: Freepik) The insurance sector has been through a turmoil lately, coupled with ...

If anyone can make a plain T-shirt look enviably chic, it’s Dua Lipa.

Federal Bank shares have received a buy call from global brokerage CLSA. Initiating coverage on the banking stock, CLSA said the bank is eyeing return metrics closer to those of the six large ...

Shares of Tata Motors fell 6 per cent on Friday after CLSA downgraded the stock to outperform at a lowered target price of ₹765 per share from ₹930. The stock ended 5.94 per cent lower on the ...

CLSA trims price target for IndusInd Bank but sees two positive triggers IndusInd Bank stock, which hit a 52-week low of Rs 605.40 in the previous session was trading on a flat note in the current ...

Automobile giant Tata Motors' shares continued their downward spiral, falling over five percent in trade on April 4, after Hong Kong-based brokerage CLSA downgraded its rating on the stock.

Levi’s is diving into the Britpop archives with the launch of a new collection paying homage to legendary English band blur. The Levi’s x blur Band Tee Collection dropped globally on April 10, ...

India's electronics manufacturing, especially smartphones, are set to gain a competitive edge as the US imposes tariffs on electronics imports from key countries, says a CLSA report. The shift in ...

However, international brokerage CLSA allayed concerns, stating that the risk of high tariffs on pharma products is low. “The pharma is going to be starting to come in at, I think, a level that ...